Kupando receives 13 million euros
Jan Schulte
| Stuttgart,26.09.2022
The start-up was able to convince Remiges Ventures and High-Tech Gründerfonds, among others, in its Series A financing round.
Biopharma start-up Kupando has raised €13 million in its Series A financing round. Venture capitalist Remiges Ventures leads the round. Co-lead investor is Lifecare Partners, with money also coming from Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and several family offices.
Kupando is developing substances to stimulate innate immunity against cancer and other infectious diseases. The start-up says it has a drug candidate, KUP101, for which it now plans to apply for a clinical trial. "It's really nice that we now have the opportunity to develop compounds that can make a difference in the treatment of solid tumors and the prevention of infectious diseases in terms of efficacy, safety and financial affordability," says Johanna Holldack, CEO of Kupando.
The startup also receives praise from its lead investor. "Kupando is a true pioneer in the development of a novel innate immunity stimulator, and we look forward to working with the team and supporting the advancement of KUP101 into clinical development," says Kazuhiko Nonomura of Remiges Ventures.
Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies
Investor
2005
Bonn
High-Tech Gründerfonds
HTGF is one of the leading and most active early-stage investors in Germany and Europe.
Investor
2000
Potsdam
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?
